Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: Subanalysis of the phase 3 VISTA study

Meletios A. Dimopoulos, Maria Victoria Mateos, Paul G. Richardson, Rudolf Schlag, Nuriet K. Khuageva, Ofer Shpilberg, Martin Kropff, Ivan Spicka, Antonio Palumbo, Ka Lung Wu, Dixie Lee Esseltine, Kevin Liu, William Deraedt, Andrew Cakana, Helgi Van De Velde, Jesús F. San Miguel